Skip to Main Content
Welcome to the Scientist.com Marketplace

Go to Main Navigation

36-2298-20 36-2298

Anti-MART-1 / Melan-A / MLANA (Melanoma Marker) Monoclonal Antibody(Clone: DT101 + BC199)

Abeomics

DESCRIPTION

This antibody recognizes a protein doublet of 20-22kDa, identified as MART-1 (Melanoma Antigen Recognized by T cells 1) or Melan-A. MART-1 is a newly identified melanocyte differentiation antigen recognized by autologous cytotoxic T lymphocytes. Seven other melanoma associated antigens recognized by autologous cytotoxic T cells include MAGE-1, MAGE-3, tyrosinase, gp100, gp75, BAGE-1, and GAGE-1. Subcellular fractionation shows that MART-1 is present in melanosomes and endoplasmic reticulum. This MAb labels melanomas and other tumors showing melanocytic differentiation. It is also a useful positive-marker for angiomyolipomas. It does not stain tumor cells of epithelial, lymphoid, glial, or mesenchymal origin.

DETAILS

  • Gene: MLANA
  • App Id: FACS,IF,IHC
  • Gene Id: 2315
  • Isotype: Mouse IgG2b, lambda + Mouse IgG2b, kappa
  • Clone Name: DT101 + BC199
  • Uniprot Id: Q16655
  • Host Animal: Mouse
  • Clonality Id: Monoclonal
  • Reactivity Id: Human
  • Product Content: 200 µg/ml of Ab Purified from Bioreactor Concentrate by Protein A/G. Prepared in 10mM PBS with 0.05% BSA & 0.05% azide. Also available WITHOUT BSA & azide at 1.0mg/ml.
  • Alternative Name: Antigen LB39-AA, Antigen SK29-AA, Melanoma antigen recognized by T-cells 1, MLAN-A, MLANA
  • Application Note: Flow Cytometry (1-2ug/million cells); Immunofluorescence (1-2ug/ml); Immunohistochemistry (Formalin-fixed) (1-2ug/ml for 30 minutes at RT)(Staining of formalin-fixed tissues requires heating tissue sections in 10mM Tris with 1mM EDTA, pH 9.0, for 45 min at 95&degC followed by cooling at RT for 20 minutes);
  • Storage Condition: Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous.
  • Immunogen Information: Recombinant hMART-1 protein (DT101 & BC199)